Diseases & Longevity · File 34

Severe pneumonia. Sustained mortality beyond discharge — and CV events in the following months.

Severe community-acquired pneumonia remains one of the main causes of hospitalization and infectious disease mortality. In hospitalized adults, 1-year mortality exceeds 25% — particularly in older adults. After the event, there's increased risk of cardiovascular events (MI, stroke, HF) in months-years that follow (Corrales-Medina 2015). Longevity medicine operates in prevention (vaccination) and in post-event trajectory.

Why pneumonia is a longevity inflection event

Pneumonia severe enough to require hospitalization is a frailty marker — particularly in older adults. Beyond acute management (empirical + targeted antibiotic therapy by etiology, ventilatory support, complication management), post-event trajectory defines real longevity. 1-year mortality exceeds 25% in hospitalized adults, and survivors carry deconditioning, sarcopenia, and added cardiovascular risk.

Corrales-Medina et al. (JAMA 2015) quantified something decisive: cardiovascular event risk (MI, stroke, HF) significantly increases in months-years post-severe pneumonia — combined mechanism of sustained inflammaging, hypercoagulability, and endothelial damage. Adequate vaccination (pneumococcus PCV13/PCV20/PPSV23 per age and comorbidities, annual influenza, COVID-19, RSV in older adults) is the highest-impact preventive intervention. Longevity medicine operates there and in post-event trajectory.

Pneumonia doesn't end when the antibiotic ends. Added CV risk and post-event trajectory are where longevity operates.
Events months post-pneumonia

The global weight, in numbers

Data come from GBD, IDSA/ATS, Corrales-Medina, and post-event meta-analyses. They confirm the importance of prevention and post-discharge trajectory.

  • Sustained mortality

    >25% a 1 año

    In adults hospitalized for severe pneumonia, 1-year mortality exceeds 25% — particularly in >65, with multiple comorbidities or preexisting frailty. Vulnerability marker.
    — Mortensen et al., Am J Med 2003

  • Post-event CV events

    Riesgo aumentado meses-años

    Corrales-Medina 2015 (JAMA): cardiovascular event risk (MI, stroke, HF) significantly increases in months-years post-severe pneumonia — sustained effect in longitudinal cohorts.
    — Corrales-Medina et al., JAMA 2015

  • Pneumococcal vaccination

    PCV13/PCV20/PPSV23

    Pneumococcal vaccination (PCV13, PCV20 conjugates, PPSV23 polysaccharide) reduces pneumococcal pneumonia and invasive disease in older and high-risk adults. Schemes per ACIP, considering age, comorbidities, and prior vaccines.
    — ACIP 2024 Recommendations

  • Influenza, COVID-19, RSV

    Cobertura ampliada

    Adequate annual influenza, COVID-19 per current schemes, and RSV vaccination in older adults (approved 2023+ vaccines) are preventive interventions with demonstrated effect. Integration with vaccinal cluster is modern standard.
    — CDC ACIP 2024

Chap. 03 · Systemic post-pneumonia

The post-event cluster that longevity medicine complements

The severe pneumonia survivor carries deconditioning, added CV risk, and amplified comorbidities — that's where longevity trajectory operates.

  • Physical deconditioning

    Sarcopenia post-evento

    Hospitalization for severe pneumonia — particularly with mechanical ventilation — induces significant muscle mass and strength loss. Structured rehabilitation (progressive strength + adapted cardio) is critical for functional recovery.
    — Herridge et al., NEJM 2011

  • Sustained added CV risk

    Inflammaging persistente

    Post-pneumonia inflammaging persists for months, contributing to cardiovascular acceleration. Intensive management of traditional factors (ApoB, BP, glucose) in survivors is effective indirect CV prevention.
    — Corrales-Medina JAMA 2015

  • Post-event mental health

    Depresión / ansiedad

    Clinical depression and anxiety are frequent post-severe pneumonia — particularly in ICU survivors with delirium or prolonged ventilation. Screening and management are integral to post-event trajectory.
    — Davydow et al., Gen Hosp Psychiatry 2008

  • Vaccination and recurrence prevention

    ACIP esquemas modernos

    After a severe pneumonia event, complete vaccination update (pneumococcus, influenza, COVID-19, RSV in older, herpes zoster in >50, Tdap, consider others per profile) is priority. Reduces recurrence and associated events.
    — ACIP 2024

What we don't offer — and what we do

Wellness Care does not manage acute pneumonia or hospitalization. Empirical + targeted antibiotic therapy, ventilatory support, parapneumonic effusion / empyema management, ICU decision, and all acute phase decisions are exclusively hospital and pulmonology / infectious diseases competence. What we do: prevention with adequate vaccination, post-discharge assessment, added CV risk management, and functional rehabilitation.

We evaluate: older adults and/or those with multiple comorbidities wanting to optimize prevention (vaccination, cardiometabolic cluster), severe pneumonia survivors post-discharge with deconditioning, sarcopenia, unmanaged added CV risk, post-event depression / anxiety, or those wanting to reduce recurrence risk. Coordination with treating physician, pulmonology, cardiology, and mental health when indicated.

Pneumonia doesn't end when the antibiotic ends. Prevention with vaccination and added CV risk management are where longevity operates.
How we measure it

How prevention and post-event
are addressed at Wellness Care

Prevention (adequate vaccination) + post-event trajectory (rehabilitation + added CV + mental health). In coordination with pulmonology and cardiology when indicated.

Advanced biomarkers

21 specialized panels across 8 clinical categories — biological age, inflammaging, metabolic profile, functional hormonal, microbiota. The quantitative layer.

Explore →

Functional medicine

Shared root causes — mitochondrial dysfunction, inflammaging, neuroendocrine dysregulation — before organ pathology.

Explore →

Bioregulatory medicine

Autonomic regulation, HRV, stress response. The functional trajectory that precedes clinical diagnosis.

Explore →

The Longevity Program

How this assessment integrates into the full program — from initial valuation to individualized protocol design under medical judgment.

Explore →
Featured evidence

Key evidence supporting this approach

Four publications — post-CAP mortality, post-pneumonia CV events, post-ICU deconditioning, vaccination.

«La mortalidad a 1 año tras hospitalización por neumonía severa supera el 25% en adultos mayores — marcador de fragilidad y vulnerabilidad sostenida.»
Am J Med · 2003
Mortensen et al., 2003
Mortalidad post-NAC
«El riesgo de eventos cardiovasculares aumenta significativamente en los meses-años post-neumonía severa — efecto sostenido en cohortes longitudinales.»
JAMA · 2015
Corrales-Medina et al., 2015
CV post-neumonía
«La rehabilitación física estructurada tras hospitalización con ventilación mecánica es crítica para recuperar masa y fuerza muscular.»
NEJM · 2011
Herridge et al., NEJM 2011
Rehabilitación post-UCI

Frequently asked questions about severe community-acquired pneumonia

The most recurrent questions about severe pneumonia — vaccination, post-event CV risk, rehabilitation, and why longevity medicine complements medical follow-up.

01

What vaccines should I have updated to prevent pneumonia?

ACIP 2024 recommendations:

· Pneumococcal — PCV20 or PCV15+PPSV23 per scheme, in adults ≥50 or ≥19 with risk conditions
· Annual influenza in all adults
· COVID-19 per current scheme
· RSV (approved 2023+ vaccines) in adults ≥60 or with comorbidities
· Herpes zoster (Shingrix) in ≥50

Specific decision and scheme depend on clinical profile — treating physician / infectious diseases.

02

Why does CV risk increase after severe pneumonia?

Due to sustained inflammaging.

Severe infection induces inflammatory activation that persists for months post-event:

· Elevated hsCRP
· Elevated fibrinogen
· Cytokines

Produce:

· Endothelial dysfunction
· Hypercoagulability
· Atherosclerotic acceleration

Result: higher risk of MI, stroke, and HF in following months-years.

Intensive management of traditional factors (ApoB, BP, glucose) and antiplatelet per indication reduces added risk.

03

When should I consult?

An assessment is worthwhile if:

· You're an older adult or with multiple comorbidities wanting to optimize prevention (vaccination + cardiometabolic cluster)
· You're a severe pneumonia survivor with:
  · Deconditioning
  · Sarcopenia
  · Added CV risk
  · Post-event depression
· Want to reduce recurrence risk

The assessment complements treating physician and pulmonology — does not replace them.

Beyond the antibiotic

Pneumonia doesn't end when the antibiotic ends — added CV risk and post-event trajectory are where longevity operates.

Adequate vaccination (ACIP), post-event rehabilitation, intensive added CV risk management, and coordination with treating physician — that changes sustained trajectory.

Severe pneumonia survivor or vaccination?

Book a respiratory and longevity assessment

We evaluate clinical history, vaccination status (pneumococcus, influenza, COVID-19, RSV per indication), residual pulmonary function, post-event cardiovascular profile, body composition, mental health, and cardiometabolic cluster. Does not replace pulmonology / infectious diseases — complements them.

Book post-pneumonia assessment